Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

CBA share price to hit $65, says UBS ahead of full-year report

We examine how UBS analysts view the Commonwealth Bank of Australia heading into the bank’s full-year results.

CBA Source: Bloomberg

Analysts remain Underweight CBA

With the Commonwealth Bank of Australia (CBA) set to report its full-year (FY20) results in two days, we unpack one key investment bank’s thoughts on the bank.

Overall, the sell-side has grown increasingly bearish on the biggest of the big four banks over the last month, with the consensus rating shifting from a Hold rating one month ago, to its current rating of Underweight, according to the Wall Street Journal.

On a more granular level, only 2 analysts have Buy ratings on CBA, against 5 Hold ratings, 1 Underweight Rating and 6 Sell ratings, also according to the Wall Street Journal.

Of those analysts, UBS sits somewhere in the middle, assigning Commonwealth a Neutral rating and price target of $65.00 per share – implying some downside from current price levels.

As with Citibank’s analysis of the sector, UBS analysts, in a recent note on the banks, have paid special attention to the Australian Prudential Regulation Authority’s (APRA) recent regulatory guidance around expectations concerning authorised deposit taking institutions (ADIs) and their capital management strategies.

Here it was noted that ADIs should ‘seek to retain at least half of their earnings when making decisions on capital distributions (and utilise dividend reinvestment plans and other initiatives to offset the diminution in capital from capital distributions where possible).’

ADIs are also expected to regularly conduct stress tests and continue to support Australian households and business through ongoing lending.

How this regulatory guidance may influence the banks has proven to be a divisive point among analysts, with Citi analysts expecting the biggest of the big four banks to pay a final dividend of 50 cents per share, bringing CBA’s total payout to 250 cents per share. By comparison, UBS expects Commonwealth to pay a final dividend of 95 cents per share – equating to a 50% payout, by the investment bank’s calculations. Though ahead of consensus, USB argues that a dividend of that magnitude is supported by the bank’s strong capital position and recent asset sales.

Even so, more broadly commenting on the sector and investor expectations, it was noted that:

‘We believe all shareholders must recognise that bank dividends are not an annuity, especially during the depths of a recession with 11% of mortgages and 17% of SME loans on deferral, and with 25% of the population returning to lockdown.’

CBA share price: Other bits and pieces to consider

Overall, UBS expects CBA to report core earnings of $13,394 million, against cash earnings per share (EPS) of 432 cents.

Elsewhere, investors will likely be eager to see updated figures on the bank’s loan deferrals – given the recent lockdowns in Melbourne, one of Australia’s key states – both in terms of economic activity and from a property market perspective.

Overall, of the approximately 240,000 loan deferral requests CBA reported in April – 25,000 were personal loans, 70,700 were business loans (of balances totalling $15.2 billion) and 144,000 were home loans (of balances totalling $50 billion).

Cautiously, UBS warned that ‘CBA could experience an uptick in impairment charges in FY21E as government stimulus and loan deferrals come to an end.’

Want to take a position in CBA, long or short?

Create an IG trading account or log in to your existing account to get started now.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access
Learn more

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.